Yale School of Medicine
University of Calgary, 2002, BSc, Cell Molecular Biology; Harvard University, 2008, PhD, Biological Sciences
Combines expertise in genomics, CRISPR-engineering, neuroscience, and human-induced pluripotent stem cells.
Established the first human cell models of brain disease, demonstrating that critical aspects of disease etiology can be recapitulated in the laboratory dish. Her research is helping to decode highly complex genetic insights into medically actionable information, towards improving diagnostics, predicting clinical trajectories, and identifying points of therapeutic intervention.